Homocystinuria And Other Aminoacidopathies

Homocystinuria

Homocystinuria is a genetic metabolic disorder characterized by abnormalities in the synthesis and breakdown of methionine, an essential amino acid that contains sulfur. This leads to the accumulation of homocysteine, a harmful intermediate metabolite, which causes damage to various organ systems throughout the body.

The term "homocystinuria" is often used interchangeably with "homocystemia," which refers to the presence of elevated levels of homocysteine in the blood or other bodily fluids. Elevated homocysteine levels can cause a range of health problems, including thrombosis, neurological disorders, and impaired kidney function. Treatment for homocystinuria typically involves supplementation with folic acid and vitamin B12, as well as dietary restrictions to manage the condition.

Molecular Basis Of The Disease  

Molecular foundation reaction transforms methionine into an intermediate form called S-Adenosyl Methionine (SAM), as seen in the image. Homocysteine is formed by SAM from another intermediate known as S-Adenosyl homocysteine. Two outcomes await this homocysteine: one, it will create the intermediate cystathionine, which will thereafter be transformed into another amino acid called L-cysteine; and two, some of it is converted back into methionine through the action of methionine synthase enzyme. In order for this reaction to occur, methylcobalamin is an essential component that enables the methionine synthase to function properly.

The Three Reasons For The Occurrence Of Homocystinuria 

In almost 95% of cases, homocystinuria, the most significant classical illness, is caused by a lack of the enzyme cystathionine beta-synthase (CBS). A methylcobalamin deficiency will be indicated if methionine synthase is not functioning. Methylenetetrahydrofolate Reductase (MTHF Reductase) deficiency.

Consequently, the condition known as homocystinuria is described as one in which the body accumulates homocysteine through the methionine catabolism pathway.

Side Note

The distinction between homocysteine and homocysteine is that homocysteine is created when two homocysteine molecules bind together via a sulfur bridge.

MC Type: Classic Homocystinuria

Classic homocystinuria, an autosomal recessive disorder, is associated with mutations in the CBS gene located on chromosome 21q22.3. The defective enzyme cystathionine beta-synthase (CBS) causes the accumulation of toxic amino acids in the body, leading to a range of symptoms including thromboembolic events, cognitive impairment, and growth retardation. While some newborns with classic homocystinuria may not show any initial symptoms, most children begin to seek medical attention around age three due to delayed development or failure to thrive.

Also Read: Approach And Basics Of Inborn Errors Of Metabolism

Clinical Manifestations of Homocystinuria

The clinical manifestations of Homocystinuria are broadly divided into four categories. 

1. Ocular
   • Hall mark 
     • ECTOPIA LENTIS (sublux of lens) 
       • B/L symm
       • Infero-nasal 
   • Prodcues 
     • Myopia 
     • Tremulous iris (Iridodonensis) 
2. CNS
   • Progressive MR 
   • Psych & behave. Changes (50%) 
   • Seizures (20%) 
   • Psychosis 
3. Skeletal
   • Marfanoid habitus 
   • Pes cavus 
   • Peches carinatum peches ex. 
4. Others 

Ocular

 The most prevalent manifestation of homocystinuria, sometimes referred to as a hallmark finding, is a disease termed ectopia lentis, which is characterized by subluxation of the eye's lens. • Ocular manifestations include the initial presentation or hallmark presentation.
The normal onset age of this subluxation is between 3 and 8 years old.  Ectopia lentis is inferonasal (down and towards the nasal side) and bilaterally symmetrical (affecting both eyes).
The youngster develops severe myopia and tremulous iris, commonly known as iridodonesis.

Central Nervous System (CNS)

The CNS will become involved, resulting in gradual mental impairment.  In 50% of the patients, there will be psychiatric and behavioral alterations, which could be settling behavior modifications or frank conditions. Furthermore, about 20% of the individuals have seizures.  Another extremely uncommon feature could be psychosis.

Skeletal

Many patients have skeletal anomalies such as Pes cavus, Pectus carinatum, or Pectus excavatum.  The individuals exhibit clinical manifestations of Marfanoid habitus, which includes long, slender limbs and arachnoid ductile.
They might exhibit characteristics including scoliosis, a high arched palate, and tooth crowding.

Other Manifestations

In addition to blue eyes and white skin, the other symptoms usually include a mild malar rash or malar erythema.

Complications

Thromboembolism

Thromboembolism is the most frequent and significant complication. Homocysteine increases the risk of thromboembolism due to a number of factors, including oxidative stress (which increases the formation of free radicals), endothelial damage, abnormal angiogenesis, and decreased fibrinolytic activity.

It can affect the brain as well as occur at any age. It is thought to be the reason homocystinuria patients die. At a relatively young age, myocardial infarction can occur from the milder variants.

Ocular

The complication may include optic atrophy, retinal detachment, cataracts, glaucoma, and an elevated risk of staphylomas.

Increased Risk of Vertebral Fractures

The X-ray spine examination reveals that this issue is caused by generalized osteopenia. Osteopenia is present even in childhood, but it becomes worse with age, and in mid-adulthood, the person will have vertebral fractures that result in paraparesis and paraplegia.

Other Rare Complications 

Spontaneous pneumothorax and acute pancreatitis are two other uncommon consequences.

Diagnosis                                                 

Although it is regarded as non-specific, the urine nitroprusside test is utilized as a screening test for diagnosis.  Only in classical illness, not in the other two variations, are plasma levels of homocysteine and methionine increased.

 Low amounts of cystine.  Commercially available tests for this condition now include enzyme assays and genetic testing.

Treatment                                           

Pyridoxine, or vitamin B6, plays a major part in the treatment. It has been demonstrated that pyridoxine increases the deficient enzyme activity, or CBS. As a result, the first line of treatment should always start with a high dose of vitamin B6, such as 100–500 mg daily.

Since many individuals with unresponsive vitamin B6 respond better when B12 is added, the treatment may additionally include folate and vitamin B12. In the event that this isn't feasible, patients can use Betaine (trimethylglycine), an additional medication that decreases homocysteine levels by remethylating homocysteine to methionine.

According to the studies, visual abnormalities and mental retardation might be avoided in children who received B6 and Betaine therapy within their first year of life.Early diagnosis and treatment are so crucial. Methionine eventually turns into homocysteine, thus food restrictions are necessary for patients who are not sensitive to either treatment. Supplementing with cysteine is necessary since they are not forming.

Variants 

Homocystinuria

Because of Inadequate Formation of Methylcobalamin  The cofactor needed to convert homocysteine back into methionine is methylcobalamin. Homocysteine will therefore rise in the absence of it since it will not be converted into methionine.

In the conventional illness, both homocysteine and methionine are increased; in this variant, only homocysteine is raised.
There are seven different kinds of enzymes that have been identified: cbl-C, cbl-D, cbl-E, cbl-F, cbl-G, cbl-J, and cbl-X. 

It is possible for certain types to additionally have methylmalonic acidemia.  Since only homocysteine is raised in these disorders, the absence of hypermethioninemia sets them apart from traditional illnesses. Hydroxocobalamin, or vitamin B12, at a high dosage, is the treatment for this illness.

Homocystinuria 

Because to a deficiency in methylenetetrahydrofolate reductase (MTHF Reductase)  This disorder is primarily neurological in nature, with the potential for thromboembolism.  Ocular characteristics could be uncommon.

Nitrous oxide gas anesthesia can be fatal due to central nervous system poisoning.  Unlike classical illness, this condition exhibits the absence of hypermethioninemia.
Folic acid, vitamin B6, vitamin B12, supplemented methionine, and betaine are all included in the treatment. Nelson claims that while betaine produced the best results, total therapy response is subpar when compared to other approaches.

Cystathioninemia 

The disease known as cystathioninemia is rare but can occur in a non-genetically acquired form when the conversion of cystathione into L-Cysteine is blocked. Cystathioninemia has a primary form that results from a deficiency in the enzyme cystathionase.Based on Nelson's 21st edition, there is little clinical significance.

Cystathioninuria

In contrast, the same disorder is known as cystathioninuria when it occurs in the urine.It is most frequently observed in a secondary form that can result from a number of other conditions, including liver illness, neuroblastoma, ganglioblastoma, thyrotoxicosis, vitamin B6 and B12 deficiencies, and homocysteine remethylation abnormalities.

Also Read: NEET SS Pediatrics Growth and Development Questions

Hope you found this blog helpful for your Inborn Errors of Metabolism NEET SS pediatrics preparation. For more informative and interesting posts like these, keep reading PrepLadder’s blogs.